Mrs Jolene Loree Dittmer, LPNC | |
1715 26th St, Central City, NE 68826-9501 | |
(308) 946-3015 | |
(308) 946-5914 |
Full Name | Mrs Jolene Loree Dittmer |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 1715 26th St, Central City, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770997827 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 6675 (Nebraska) | Primary |
164W00000X | Licensed Practical Nurse | 465 (Nebraska) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Mrs Jolene Loree Dittmer, LPNC 12849 A Rd, Clarks, NE 68628-6001 Ph: (308) 548-8114 | Mrs Jolene Loree Dittmer, LPNC 1715 26th St, Central City, NE 68826-9501 Ph: (308) 946-3015 |
News Archive
NewYork-Presbyterian Hospital/Columbia University Medical Center is the first hospital in the New York metro area to offer breast cancer survivors an at-home method for tissue expansion in preparation for breast reconstruction surgery. Patients use a remote control to gradually create a space within their chest wall for a breast implant.
The U.S. Food and Drug Administration approves only 13.8% of all tested drugs, and these numbers are even lower in "orphan" diseases that affect relatively few people.
States face a Friday deadline to indicate whether they plan to establish their own online health insurance markets, or allow the federal government to do it. Meanwhile, debate continues about whether delays in updating essential software and other glitches could delay the start of enrollment in the markets beyond the Oct. 1, 2013 target specified in the health law.
BioTrackTHC, the top provider of seed-to-sale software solutions for medical and retail marijuana businesses, today announced a strategic alliance with Adherence Colorado, the leading provider of compliance audits and inventory reconciliation for the cannabis industry.
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
› Verified 8 days ago
Connie Loseke, LPN-C Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1715 26th St, Central City, NE 68826 Phone: 308-946-3015 | |
Lavone Solomon, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1715 26th St, Central City, NE 68826 Phone: 308-946-3015 Fax: 308-946-2633 | |
Tina Lynn Schnitzler, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2510 18th Ave, Central City, NE 68826 Phone: 308-946-3845 Fax: 308-946-2145 |